Fulton, Robbins Sweep RUI Adequan Derby

Tres Seis filly earns a trip to Prairie Meadows with a victory at Ruidoso Downs.

June 30, 2012

Pandorum and favored Sweet Oblivion, a pair of Joe Kirk Fulton homebreds trained by Mike Robbins, stood out with a one-two finish in the $45,450 Adequan Ruidoso Derby Challenge on Saturday afternoon at Ruidoso Downs.
Pandorum, with Roy Baldillez aboard, opened up a clear advantage in the 400-yard stakes at odds of 9-2, and Sweet Oblivion tried to make a late run at her stable mate but came up one-length short.
Mr Taka B finished third, 1 3/4 lengths behind Sweet Oblivion.
Fulton and Robbins were a dominant force for years and reached the sport’s pinnacle when they combined to race 1984 world champion Dashs Dream, widely considered one the all-time great Quarter Horse mares. Fulton and Robbins are now back together with horses showing promise at Ruidoso Downs.
Pandorum finished second in her Adequan Ruidoso Derby Challenge trial after losing her footing at the start. The filly got off to a strong start this time and the result was her second stakes win. Last year, the Tres Seis daughter won the John Deere Sam Houston Juvenile Challenge (G3). The Adequan Ruidoso Derby Challenge victory was her fourth win from six starts and qualifies her to race in the $200,000 Adequan Derby Challenge Championship (G1) on October 27 at Prairie Meadows.
Sweet Oblivion was the 4-5 favorite after a devastating trial performance when she won by 3 ½ lengths with the fastest-qualifying time of :19.867. A daughter of Mr Jess Perry, Sweet Oblivion won one of two starts last year and scored two wins in as many starts this year before her runner-up effort in the Adequan Ruidoso Derby Challenge.
Debra Gotovac’s 2010 Rainbow Derby (G1) winner Swingin Daddyo led the post parade for the Adequan Ruidoso Derby Challenge and was then retired in the winner’s circle. Gotovac is a breast cancer survivor, and Saturday was “Pink Day at the Races” to raise funds to increase breast cancer awareness and early detection of the disease that is predicted to take 40,000 lives this year.